Global Peyronie’s Disease Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 75 pages | ID: G948B4229483EN
LP Information

Abstracts

According to this study, the global Peyronie’s Disease Treatment market size will reach US$ 998 million by 2031.

Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Peyronie’s Disease Treatment Industry Forecast” looks at past sales and reviews total world Peyronie’s Disease Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Peyronie’s Disease Treatment sales for 2025 through 2031. With Peyronie’s Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peyronie’s Disease Treatment industry.

This Insight Report provides a comprehensive analysis of the global Peyronie’s Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peyronie’s Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peyronie’s Disease Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peyronie’s Disease Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peyronie’s Disease Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Peyronie’s Disease Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Drugs
• Surgery

Segmentation by Application:

• Hospital
• Drugs Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Endo International
• Asahi Kasei
• BioSpecifics Technologies

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Peyronie’s Disease Treatment Market Size (2020-2031)
  2.1.2 Peyronie’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Peyronie’s Disease Treatment by Country/Region (2020, 2024 & 2031)
2.2 Peyronie’s Disease Treatment Segment by Type
  2.2.1 Drugs
  2.2.2 Surgery
2.3 Peyronie’s Disease Treatment Market Size by Type
  2.3.1 Peyronie’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
2.4 Peyronie’s Disease Treatment Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
2.5 Peyronie’s Disease Treatment Market Size by Application
  2.5.1 Peyronie’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)

3 PEYRONIE’S DISEASE TREATMENT MARKET SIZE BY PLAYER

3.1 Peyronie’s Disease Treatment Market Size Market Share by Player
  3.1.1 Global Peyronie’s Disease Treatment Revenue by Player (2020-2025)
  3.1.2 Global Peyronie’s Disease Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Peyronie’s Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEYRONIE’S DISEASE TREATMENT BY REGION

4.1 Peyronie’s Disease Treatment Market Size by Region (2020-2025)
4.2 Global Peyronie’s Disease Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peyronie’s Disease Treatment Market Size Growth (2020-2025)
4.4 APAC Peyronie’s Disease Treatment Market Size Growth (2020-2025)
4.5 Europe Peyronie’s Disease Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Peyronie’s Disease Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Peyronie’s Disease Treatment Market Size by Country (2020-2025)
5.2 Americas Peyronie’s Disease Treatment Market Size by Type (2020-2025)
5.3 Americas Peyronie’s Disease Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Peyronie’s Disease Treatment Market Size by Region (2020-2025)
6.2 APAC Peyronie’s Disease Treatment Market Size by Type (2020-2025)
6.3 APAC Peyronie’s Disease Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Peyronie’s Disease Treatment Market Size by Country (2020-2025)
7.2 Europe Peyronie’s Disease Treatment Market Size by Type (2020-2025)
7.3 Europe Peyronie’s Disease Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Peyronie’s Disease Treatment by Region (2020-2025)
8.2 Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PEYRONIE’S DISEASE TREATMENT MARKET FORECAST

10.1 Global Peyronie’s Disease Treatment Forecast by Region (2026-2031)
  10.1.1 Global Peyronie’s Disease Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Peyronie’s Disease Treatment Forecast
  10.1.3 APAC Peyronie’s Disease Treatment Forecast
  10.1.4 Europe Peyronie’s Disease Treatment Forecast
  10.1.5 Middle East & Africa Peyronie’s Disease Treatment Forecast
10.2 Americas Peyronie’s Disease Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Peyronie’s Disease Treatment Forecast
  10.2.2 Canada Market Peyronie’s Disease Treatment Forecast
  10.2.3 Mexico Market Peyronie’s Disease Treatment Forecast
  10.2.4 Brazil Market Peyronie’s Disease Treatment Forecast
10.3 APAC Peyronie’s Disease Treatment Forecast by Region (2026-2031)
  10.3.1 China Peyronie’s Disease Treatment Market Forecast
  10.3.2 Japan Market Peyronie’s Disease Treatment Forecast
  10.3.3 Korea Market Peyronie’s Disease Treatment Forecast
  10.3.4 Southeast Asia Market Peyronie’s Disease Treatment Forecast
  10.3.5 India Market Peyronie’s Disease Treatment Forecast
  10.3.6 Australia Market Peyronie’s Disease Treatment Forecast
10.4 Europe Peyronie’s Disease Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Peyronie’s Disease Treatment Forecast
  10.4.2 France Market Peyronie’s Disease Treatment Forecast
  10.4.3 UK Market Peyronie’s Disease Treatment Forecast
  10.4.4 Italy Market Peyronie’s Disease Treatment Forecast
  10.4.5 Russia Market Peyronie’s Disease Treatment Forecast
10.5 Middle East & Africa Peyronie’s Disease Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Peyronie’s Disease Treatment Forecast
  10.5.2 South Africa Market Peyronie’s Disease Treatment Forecast
  10.5.3 Israel Market Peyronie’s Disease Treatment Forecast
  10.5.4 Turkey Market Peyronie’s Disease Treatment Forecast
10.6 Global Peyronie’s Disease Treatment Forecast by Type (2026-2031)
10.7 Global Peyronie’s Disease Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Peyronie’s Disease Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Endo International
  11.1.1 Endo International Company Information
  11.1.2 Endo International Peyronie’s Disease Treatment Product Offered
  11.1.3 Endo International Peyronie’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Endo International Main Business Overview
  11.1.5 Endo International Latest Developments
11.2 Asahi Kasei
  11.2.1 Asahi Kasei Company Information
  11.2.2 Asahi Kasei Peyronie’s Disease Treatment Product Offered
  11.2.3 Asahi Kasei Peyronie’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Asahi Kasei Main Business Overview
  11.2.5 Asahi Kasei Latest Developments
11.3 BioSpecifics Technologies
  11.3.1 BioSpecifics Technologies Company Information
  11.3.2 BioSpecifics Technologies Peyronie’s Disease Treatment Product Offered
  11.3.3 BioSpecifics Technologies Peyronie’s Disease Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 BioSpecifics Technologies Main Business Overview
  11.3.5 BioSpecifics Technologies Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Peyronie’s Disease Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Peyronie’s Disease Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drugs
Table 4. Major Players of Surgery
Table 5. Peyronie’s Disease Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Peyronie’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 8. Peyronie’s Disease Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Peyronie’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 11. Global Peyronie’s Disease Treatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Peyronie’s Disease Treatment Revenue Market Share by Player (2020-2025)
Table 13. Peyronie’s Disease Treatment Key Players Head office and Products Offered
Table 14. Peyronie’s Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Peyronie’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Peyronie’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 19. Global Peyronie’s Disease Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Peyronie’s Disease Treatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Peyronie’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Peyronie’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Peyronie’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
Table 25. Americas Peyronie’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Peyronie’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Peyronie’s Disease Treatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Peyronie’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Peyronie’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Peyronie’s Disease Treatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Peyronie’s Disease Treatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Peyronie’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Peyronie’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Peyronie’s Disease Treatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Peyronie’s Disease Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Peyronie’s Disease Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Peyronie’s Disease Treatment
Table 39. Key Market Challenges & Risks of Peyronie’s Disease Treatment
Table 40. Key Industry Trends of Peyronie’s Disease Treatment
Table 41. Global Peyronie’s Disease Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Peyronie’s Disease Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Peyronie’s Disease Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Peyronie’s Disease Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Endo International Details, Company Type, Peyronie’s Disease Treatment Area Served and Its Competitors
Table 46. Endo International Peyronie’s Disease Treatment Product Offered
Table 47. Endo International Peyronie’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Endo International Main Business
Table 49. Endo International Latest Developments
Table 50. Asahi Kasei Details, Company Type, Peyronie’s Disease Treatment Area Served and Its Competitors
Table 51. Asahi Kasei Peyronie’s Disease Treatment Product Offered
Table 52. Asahi Kasei Peyronie’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Asahi Kasei Main Business
Table 54. Asahi Kasei Latest Developments
Table 55. BioSpecifics Technologies Details, Company Type, Peyronie’s Disease Treatment Area Served and Its Competitors
Table 56. BioSpecifics Technologies Peyronie’s Disease Treatment Product Offered
Table 57. BioSpecifics Technologies Peyronie’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. BioSpecifics Technologies Main Business
Table 59. BioSpecifics Technologies Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Peyronie’s Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Peyronie’s Disease Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Peyronie’s Disease Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Peyronie’s Disease Treatment Sales Market Share by Country/Region (2024)
Figure 8. Peyronie’s Disease Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Peyronie’s Disease Treatment Market Size Market Share by Type in 2024
Figure 10. Peyronie’s Disease Treatment in Hospital
Figure 11. Global Peyronie’s Disease Treatment Market: Hospital (2020-2025) & ($ millions)
Figure 12. Peyronie’s Disease Treatment in Drugs Store
Figure 13. Global Peyronie’s Disease Treatment Market: Drugs Store (2020-2025) & ($ millions)
Figure 14. Global Peyronie’s Disease Treatment Market Size Market Share by Application in 2024
Figure 15. Global Peyronie’s Disease Treatment Revenue Market Share by Player in 2024
Figure 16. Global Peyronie’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Peyronie’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Peyronie’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Peyronie’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Peyronie’s Disease Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Peyronie’s Disease Treatment Value Market Share by Country in 2024
Figure 22. United States Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Peyronie’s Disease Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Peyronie’s Disease Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Peyronie’s Disease Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Peyronie’s Disease Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Peyronie’s Disease Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Peyronie’s Disease Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Peyronie’s Disease Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Peyronie’s Disease Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Peyronie’s Disease Treatment Market Size 2026-2031 ($ millions)